MembersMerck Invests in Israeli Biotechnology

The German pharmaceutical company Merck, together with other international companies in the same line of business, plan to launch a fund that will invest 20 million euros ($24.6 million) in Israeli biotechnology over the next five years.

By Michael Selutin |
Photo: Nati Shohat/Flash90

Merck’s managing director, Stefan Oschmann, said in Israel: “The spirit that drives Israeli start-ups is unique and inspiring. We are proud to play an active part in this success story. We are now taking a further important step in our investments in Israel with our trust in the innovative potential of the country.”

Merck has been in existence since 1668, and is thus the oldest pharmaceutical company in the world. The company...

Israel Today Membership

Become a Member

  • Read all member content

    Get exclusive in-depth reports from Israel.

  • Get exclusive in-depth reports from Israel

    Connect with Israel, right from your home.

  • Lift up the voice of truth and hope

    Support Jerusalem-based Zionist journalism.

Already a member? .

Members

Israel Today Membership

Read all member content. Access exclusive, in-depth reports from Israel! Free Zoom events. Connect with Israel right from your home! Raise a voice of truth and hope. Support Faith-based journalism in Jerusalem!

Monthly
Membership

$5
/ month
Full access to Israel Today's Member-only content on all Digital Platforms.
Become a Member

Yearly
Membership

$46
/ year
Full access to Israel Today's Member-only content on all Digital Platforms.
Save 18% Per Month.
Become a Member

Six Months
Membership

$28
every 6 months
Full access to Israel Today's Member-only content on all Digital Platforms.
Save 9% Per Month.
Become a Member

Leave a Reply